In March, Georgia made everyone 16 and up eligible for a COVID-19 vaccine. Now, as of Monday, the rest of the country is following suit. The Biden administration says there are now enough vaccines to go around.
Health workers from the West couldn't help out in other countries due to lockdowns and restrictions. So they turned to help at home. But what is their role in lower resource countries moving forward?
The largest number of deaths have come in the United States, Brazil, Mexico, India and the United Kingdom. The pandemic death toll reached 1 million in September 2020 and 2 million in January.
In the U.S., more than 1 out of 5 residents is fully vaccinated against COVID-19. But elsewhere in the world, vaccination rates are much lower. Some poor nations have yet to receive a single dose.
No vaccine is 100% effective. Though so-called "breakthrough" COVID cases are rare, the virus is circulating widely. What's a vaccinated person to do? And ... not do?
The hope was that if people weren't out drinking, they wouldn't be spreading the coronavirus. There were unforeseen benefits to the ban, which ended last month — and negative impacts as well.
The Supreme Court has approved an inquiry into President Jair Bolsonaro's pandemic response. Doctors Without Borders says the country's approach has led to a "near collapse of Brazil's health system."
A vast network of professional vaccine skeptics on social media has been waiting for a development like the Johnson & Johnson pause. Now experts say they will milk it for all it's worth and more.
COVID-19 vaccines are highly effective but don't always provide perfect protection. Some vaccinated people later exposed to the virus still get sick. Why and how often that happens is under study.
Dr. Scott Gottlieb doesn't expect enough demand for the vaccine much beyond 160 million Americans. But he says there may eventually be enough immunity to curb the spread of the coronavirus.
A study published last month shows people with low levels of Vitamin D are at greater risk for COVID-19 infection. Despite that, the U.S. Preventative Services Task Force says there is insufficient evidence to recommend screening asymptomatic patients.
Soon after U.S. regulators paused the use of the J&J single-dose vaccine, health authorities in many European countries and in South Africa announced that they were also putting it on hold.
